X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17699) 17699
Book Review (3873) 3873
Newspaper Article (1999) 1999
Newsletter (1303) 1303
Publication (1045) 1045
Magazine Article (307) 307
Trade Publication Article (197) 197
Book Chapter (177) 177
Book / eBook (123) 123
Conference Proceeding (50) 50
Web Resource (42) 42
Transcript (18) 18
Dissertation (15) 15
Report (12) 12
Reference (6) 6
Data Set (4) 4
Paper (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14262) 14262
humans (12681) 12681
diabetic retinopathy (9284) 9284
diabetes (8419) 8419
male (7646) 7646
female (6862) 6862
middle aged (5502) 5502
ophthalmology (4807) 4807
aged (4188) 4188
adult (3805) 3805
animals (3435) 3435
endocrinology & metabolism (3399) 3399
research (2808) 2808
care and treatment (2728) 2728
risk factors (2674) 2674
diabetics (2672) 2672
diabetic retinopathy - drug therapy (2643) 2643
diabetes mellitus (2545) 2545
type 2 diabetes (2296) 2296
vascular endothelial growth factor (2133) 2133
macular degeneration (2087) 2087
retinopathy (2025) 2025
analysis (1870) 1870
retina (1839) 1839
mellitus (1812) 1812
eye diseases (1802) 1802
abridged index medicus (1768) 1768
treatment outcome (1746) 1746
drug therapy (1742) 1742
diabetes mellitus, type 2 - complications (1712) 1712
edema (1705) 1705
health aspects (1672) 1672
oxidative stress (1574) 1574
studies (1525) 1525
complications (1523) 1523
endothelial growth-factor (1523) 1523
patients (1479) 1479
rats (1447) 1447
glucose (1437) 1437
insulin (1408) 1408
medicine & public health (1391) 1391
hypertension (1365) 1365
medical research (1345) 1345
hypoglycemic agents - therapeutic use (1329) 1329
diabetes mellitus, type 2 - drug therapy (1325) 1325
disease (1315) 1315
clinical trials (1296) 1296
macular edema - drug therapy (1274) 1274
diabetes therapy (1271) 1271
follow-up studies (1229) 1229
prospective studies (1213) 1213
prevalence (1202) 1202
pharmacology & pharmacy (1175) 1175
bevacizumab (1167) 1167
aged, 80 and over (1159) 1159
angiogenesis (1136) 1136
mortality (1134) 1134
diabetic retinopathy - physiopathology (1124) 1124
intravitreal injections (1123) 1123
hyperglycemia (1118) 1118
retrospective studies (1108) 1108
insulin - therapeutic use (1105) 1105
physiological aspects (1097) 1097
inflammation (1095) 1095
medicine (1078) 1078
internal medicine (1063) 1063
blood pressure (1052) 1052
blood glucose - metabolism (1049) 1049
vascular endothelial growth factor a - antagonists & inhibitors (1035) 1035
complications and side effects (1019) 1019
development and progression (999) 999
ranibizumab (996) 996
visual acuity (985) 985
medicine, experimental (983) 983
medicine, general & internal (969) 969
risk (965) 965
mice (959) 959
nephropathy (948) 948
research article (938) 938
time factors (937) 937
diabetes mellitus, type 1 - complications (922) 922
proteins (922) 922
pharmaceutical industry (906) 906
tomography, optical coherence (900) 900
diabetes mellitus, type 1 - drug therapy (897) 897
adolescent (896) 896
diabetes mellitus, type 2 - blood (895) 895
neovascularization (889) 889
diabetic macular edema (886) 886
cardiovascular disease (876) 876
diabetic nephropathies (874) 874
genetic structures (871) 871
angiogenesis inhibitors - therapeutic use (869) 869
type 1 diabetes (868) 868
medicine, research & experimental (866) 866
diabetic-retinopathy (851) 851
drugs (846) 846
age (842) 842
glaucoma (838) 838
therapy (837) 837
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (96) 96
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (6) 6
Providence Healthcare - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Trillium Health Centre - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20963) 20963
German (191) 191
French (167) 167
Japanese (122) 122
Russian (104) 104
Spanish (59) 59
Polish (38) 38
Italian (33) 33
Romanian (24) 24
Chinese (20) 20
Czech (15) 15
Portuguese (13) 13
Korean (12) 12
Dutch (10) 10
Hungarian (9) 9
Turkish (8) 8
Danish (7) 7
Bulgarian (6) 6
Swedish (5) 5
Finnish (4) 4
Norwegian (4) 4
Arabic (3) 3
Croatian (3) 3
Hebrew (2) 2
Icelandic (1) 1
Romansh (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 11/2015, Volume 314, Issue 20, pp. 2137 - 2146
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 10, pp. 1695 - 1705.e6
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9647, pp. 1385 - 1393
Summary Background Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | LOSARTAN | RISK-FACTORS | RENIN | DISEASE | BLOOD-PRESSURE CONTROL | ANGIOTENSIN-II | ARTERY | HYPERTENSION | ENDOTHELIAL GROWTH-FACTOR | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Diabetic Retinopathy - drug therapy | Angiotensin II Type 1 Receptor Blockers - adverse effects | Double-Blind Method | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Diabetic Retinopathy - classification | Hypertension - drug therapy | Male | Dose-Response Relationship, Drug | Endpoint Determination | Hypertension - complications | Adult | Female | Tetrazoles - therapeutic use | Aged | Diabetic Retinopathy - etiology | Tetrazoles - adverse effects | Benzimidazoles - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Benzimidazoles - therapeutic use | Type 2 diabetes | Diabetic retinopathy | Complications and side effects | Candesartan | Dosage and administration | Drug therapy | Risk factors | Heart attacks | Eye diseases | Photographs | Diabetes | Patients | Index Medicus | Abridged Index Medicus | Benzimidazoles | Tetrazoles | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | Hypoglycemic Agents | Type 2 | MEDICAL AND HEALTH SCIENCES | Drug | Hypertension | drug therapy | complications | Diabetes Mellitus | classification | etiology | adverse effects | Dose-Response Relationship | therapeutic use | Diabetic Retinopathy
Journal Article
Ophthalmology, ISSN 0161-6420, 2010, Volume 117, Issue 6, pp. 1064 - 1077.e35
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article